Merck Worldwide Icon

TRADE ASSOCIATION MEMBERSHIPS

Merck is a member of numerous industry and trade groups. We work with these groups because they represent the pharmaceutical industry and business community in debates led by governments and other stakeholders, and because they are important in helping to reach industry consensus on policy issues. At times we may not share the views of our peers or associations. Merck representatives on the boards and committees of industry groups and associations ensure that we voice questions or concerns we may have about policy or related activities. We may even recuse ourselves from related association or industry group activities.

Following is a partial listing of industry and trade groups in which we are members:

Global Organizations
Business Council for International Understanding (BCIU)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
World Economic Forum
Regional & National Organizations*
American Chamber of Commerce in Japan (ACCJ)
Asia Society
Association of the British Pharmaceutical Industry (ABPI)
BioteCanada
Canada's Research-Based Pharmaceutical Companies (Rx&D)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Farmaindustria (Italy)
Farmaindustria (Spain)
Federation of Pharmaceutical Manufacturers of Japan (FPMAJ)
French Pharmaceutical Companies Association
German Association of Research-Based Pharmaceutical Companies
Japan Business Federation (Nippon Keidanren)
Japan Pharmaceutical Manufacturers Association (JPMA)
Mexican Association of Pharmaceutical Research (AMIIF)
TransAtlantic Business Dialogue (TABD)
U.S.-ASEAN Business Council
U.S.-China Business Council
U.S.-India Business Council
U.S.-Japan Business Council
United States**
Alliance for Health Reform
Biotechnology Industry Organization (BIO)
Business Roundtable
Conference Board
Council on Competitiveness
Healthcare Leadership Council
National Association of Manufacturers
National Health Council
National Pharmaceutical Council
Pharmaceutical Research and Manufacturers of America (PhRMA)
U.S. Chamber of Commerce

*We also are members of national pharmaceutical industry associations in many other countries in which we operate.

**Merck is also a member of chambers of commerce and pharmaceutical - and biotechnology-related trade associations in numerous states.

U.S. Organization Dues Used for Advocacy and/or Political Activities*
Group 2013
Amount
2012
Amount
2011
Amount
2010
Amount
Animal Health Institute**** $13,090 $10,391 $7,638 $10, 608
Bio New Jersey** $725 $1,175 $1,175 $1,625
Biotechnology Industry Organization $251,790 $285,300 $293,075 $278,800
Business Roundtable $103,646 $84,802 $106,002 $179,025
California Healthcare Institute $16,537 $10,200 $15,000 $15,000
Consumer Healthcare Products Association**** $49,500 $80,923 $91,135 $34,139
Council of the Americas** $1,250 $1,250 $1,250 $1,250
Healthcare Institute of New Jersey $118,493 $130,795 $140,820 $123,440
Healthcare Leadership Council $230,000 $120,000 $120,000 $120,000
National Association of Manufacturers*** $51,670 $51,670 $47,379 $63,171
New Jersey Lawsuit Reform Alliance $30,000 $3,000 $7,500 ---
Pennsylvania Biotechnology Association** $2,000 $2,000 $2,000 $2,000
Personal Care Products Council**** $45,254 $44,148 $31,295 $28,299
Pharmaceutical Research and Manufacturers of America $6,770,079 $6,517,099 $6,235,099 $7,046,747
Texas Healthcare & Bioscience Institute** $3,579 $3,500 $3,500 $3,500
U.S. Chamber of Commerce $675,000 $907,500 $725,000 $725,000
U.S. Global Leadership Campaign $25,000 --- --- ---
National Association for Biomedical Research $20,000 $16,000 $14,000 $12,000

*Includes associations where dues are > $25,000. Because the U.S. tax law that requires this reporting does not apply outside the United States, trade associations that are not subject to this do not provide breakouts of lobbying expenditures from membership dues.

**Prior to 2011, Merck reported the portion of dues used for advocacy and/or political activities by those associations where our dues were >$50,000. In 2011, we lowered our reporting threshold to >$25,000 in response to stakeholder input.

***Merck inadvertently did not report dues for NAM prior to 2010.

****In 2011, we began reporting trade association dues used for advocacy and/or political activities for our animal and consumer health businesses.

 

Public Policy Position Statements

Merck and Schering-Plough are now one company. We are working to update our public policy position statements to reflect our new global organization. In the meantime, please click on the links below to learn more about our views and positions.